000 01391 a2200385 4500
005 20250517075206.0
264 0 _c20170106
008 201701s 0 0 eng d
022 _a1463-1326
024 7 _a10.1111/dom.12636
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHodge, R J
245 0 0 _aTherapeutic potential of Takeda-G-protein-receptor-5 (TGR5) agonists. Hope or hype?
_h[electronic resource]
260 _bDiabetes, obesity & metabolism
_cMay 2016
300 _a439-43 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnimals
650 0 4 _aAnti-Obesity Agents
_xadverse effects
650 0 4 _aDiabetes Mellitus, Type 2
_xdrug therapy
650 0 4 _aDrug Design
650 0 4 _aDrug Discovery
_xtrends
650 0 4 _aDrug Evaluation, Preclinical
650 0 4 _aDrugs, Investigational
_xadverse effects
650 0 4 _aHumans
650 0 4 _aHypoglycemic Agents
_xadverse effects
650 0 4 _aModels, Biological
650 0 4 _aMolecular Targeted Therapy
650 0 4 _aObesity
_xdrug therapy
650 0 4 _aOrgan Specificity
650 0 4 _aReceptors, G-Protein-Coupled
_xagonists
650 0 4 _aTranslational Research, Biomedical
_xtrends
700 1 _aNunez, D J
773 0 _tDiabetes, obesity & metabolism
_gvol. 18
_gno. 5
_gp. 439-43
856 4 0 _uhttps://doi.org/10.1111/dom.12636
_zAvailable from publisher's website
999 _c25676724
_d25676724